Understanding the Interaction Between Environmental Exposures and Molecular Events in Colorectal Carcinogenesis

REFERENCES

• Parkin D. M., Muir C. S., Whelan S. L., et al. Cancer Incidence in Five Continents. International Agency for Research on Cancer, LyonFrance 1992; 6, Pub. 88
   Google Scholar
• Petrelli N., Michalek A. M., Freedman A. N., et al. Immunochemical Versus Guaiac Occult Blood Stool Tests: Results of a Community-Based Screening Program. Surg. Oncol. 1994; 3: 27–36
   PubMed Web of Science ®Google Scholar
• Sidransky D., Tokino T., Hamilton S. R., et al. Identification of ras Oncogene Mutations in the Stool of Patients with Curable Colorectal Tumors. Science 1996; 256: 102–105
   Google Scholar
• Eguchi S., Kohara N., Komuta K., et al. Mutations of the p53 Gene in the Stool of Patients with Resectable Colorectal Cancer. Cancer 1996; 77(suppl)1707–1710
   PubMedGoogle Scholar
• Gastrointestinal Tumor Study Group. Adjuvant Therapy of Colon Cancer: Results of a Prospectively Randomized Trial. N. Engl. J. Med. 1984; 310: 737–43
   PubMed Web of Science ®Google Scholar
• Greenwald P., Kelloff G. J., Boone C. W., et al. Genetic and Cellular Changes in Colorectal Cancer: Proposed Targets of Chemopreventive Agents. Cancer Epidemiol. Biomarkers Prev. 1995; 4: 691–702
   PubMed Web of Science ®Google Scholar
• Muir C., Waterhouse J., Mack T., Powell J., Whelan S., Smans M., et al. Cancer Incidence in Five Continents; International Agency for Research on Cancer. LyonFrance 1987
   Google Scholar
• Kotake K., Koyama Y., Nasu J., et al. Relation of Family History of Cancer and Environmental Factors to the Risk of Colorectal Cancer: A Case-Control Study. Jpn. J. Clin. Oncol. 1995; 25: 195–202
   PubMed Web of Science ®Google Scholar
• Potter J. D. Nutrition and Colorectal Cancer. Cancer Causes Control 1996; 7: 127–146
   PubMed Web of Science ®Google Scholar
• IARC Intestinal Microecology Group. Dietary Fiber, Transit Time, Faecal Characteristics and Large Bowel Cancer in Two Scandanavian Populations, Lancet. 1977; 2: 207–211
   Google Scholar
• Armstrong B., Doll R. Environmental Factors and Cancer Incidence and Mortality in Different Countries, with Special Reference to Dietary Practices. Int. J. Cancer 1975; 15: 617–631
   PubMed Web of Science ®Google Scholar
• Mckeown-Eyssen G., Bright-See E. Relationship Between Colon Cancer Mortality and Fiber Consumption: An International Study (abstract). Fibre in Human and Animal Nutrition, G. Wallace, L. Bell. Royal Society of New Zealand, WellingtonNew Zealand 1983
   Google Scholar
• Potter J. D., Slattery M. L., Bostick R. M., et al. Colon Cancer: A Review of the Epidemiology. Epidemiol. Rev. 1993; 15: 499–545
   PubMed Web of Science ®Google Scholar
• Willet W. C., Stampfer M. J., Colditz G. A., et al. Relation of Meat, Fat, and Fiber Intake to the Risk of Colon Cancer in a Prospective Study Among Women. N. Engl. J. Med. 1990; 323: 1664–1672
   PubMed Web of Science ®Google Scholar
• Goldbohm S. A., van den Brandt P. A., van't Veer P., et al. A Prospective Cohort Study on the Relation Between Meat Consumption and the Risk of Colon Cancer. Cancer Res. 1994; 54: 718–723
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Rimm E. B., Stampfer M. J., et al. Intake of Fat, Meat, and Fiber in Relation to Risk of Colon Cancer in Men. Cancer Res. 1994; 54: 2390–2397
   PubMed Web of Science ®Google Scholar
• Steinmetz K. A., Potter J. D. A Review of Vegetables, Fruit, and Cancer. Cancer Causes Control 1991; 2: 325–357
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Rimm E. B., Ascherio A., et al. Alcohol, Low-Methionine-Low-Folate Diets and Risk of Colon Cancer in Men. J. Natl. Cancer. Inst. 1995; 87: 265–73
   PubMed Web of Science ®Google Scholar
• Ma J., Stamper M. J., Giovannucci E., et al. Methylenetetrahydrofolate Reductase Polymorphism, Dietary Interactions, and Risk of Colorectal Cancer. Cancer Res. 1997; 57: 1098–1102
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Stampfer M. J., Colditz G. A., et al. Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study. Ann. Intern. Med. 1998; 129: 517–524
   PubMed Web of Science ®Google Scholar
• Weiss H. A., Forman D. Aspirin, NSAIDS and Protection from Colorectal Cancer: A Review of the Epidemiological Evidence. Scand. J. Gastroenterol. 1996; 220: 137–141
   Google Scholar
• Reeves M. J., Newcomb P. A., Trentham-Dietz A., et al. Nonsteroidal Anti-Inflammatory Drug Use and Protection Against Colorectal Cancer in Women. Cancer Epidemiol. Biomarkers Prev. 1996; 5: 955–960
   PubMed Web of Science ®Google Scholar
• Kauppi M., Pukkala E., Isomaki H. Low Incidence of Colorectal Cancer in Patients with Rheumatoid Arthritis. Clin. Exp. Rheumatol. 1996; 14: 551–553
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Rimm E. B., Stampfer M. J., et al. Aspirin Use and the Risk for Colorectal Cancer and Adenoma in Male Health Professionals. Ann. Intern. Med. 1994; 121: 241–246
   PubMed Web of Science ®Google Scholar
• Hoff G., Vatn M. H., Larsen S. Relationship Between Tobacco Smoking and Colorectal Polyps. Scand. J. Gastroenterol. 1987; 22: 13–16
   PubMed Web of Science ®Google Scholar
• Honjo S., Kono S., Shinchi K., et al. Cigarette Smoking, Alcohol Use and Adenomatous Polyps of the Sigmoid Colon. Jpn. J. Cancer Res. 1992; 83: 806–811
   PubMedGoogle Scholar
• Kikendall J. W., Bowen P. E., Burgess M. B., et al. Cigarettes and Alcohol as Independent Risk Factors for Colonic Adenomas. Gasteroenterology 1991; 26: 758–762
   Google Scholar
• Kune G. A., Kune S., Watson L. F., et al. Smoking and Adenomatous Polyps. Gastroenterology 1992; 103: 1370–1371, (letter)
   PubMed Web of Science ®Google Scholar
• Lee W. C., Neugaut A. I., Garbowski G. C., et al. Cigarettes, Alcohol, Coffee and Caffeine as Risk Factors for Colorectal Adenomatous Polyps. Ann. Epidemiol. 1993; 3: 239–244
   PubMedGoogle Scholar
• Martinez M. E., McPherson R. S., Annegers J. F., et al. Cigarette Smoking and Alcohol Consumption as Risk Factors for Colorectal Adenomatous Polyps. J. Natl. Cancer Inst. 1995; 87: 274–279
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Colditz G. A., Stampfer M. J., et al. A Prospective Study of Cigarette Smoking and Risk of 534 Ishibe and Freedman Colorectal Adenoma and Colorectal Cancer in U.S. Women. J. Natl. Cancer Inst. 1994; 86: 192–199
   PubMed Web of Science ®Google Scholar
• Giovannucci E., Rimm E. B., Stampfer M. J., et al. A Prospective Study of Cigarette Smoking and Risk of Colorectal Adenoma and Colorectal Cancer in U.S. Men. J. Natl. Cancer Inst. 1994; 86: 183–191
   PubMed Web of Science ®Google Scholar
• Hsing A. W., McLaughlin J. K., Chow W. H., et al. Risk Factors for Colorectal Cancer in a Prospective Study Among U.S. White Men. Int. J. Cancer 1998; 77: 549–553
   PubMed Web of Science ®Google Scholar
• Terry M. B., Neugat A. I. Cigarette Smoking and the Colorectal Adenoma-Carcinoma Sequence: A Hypothesis to Explain the Paradox. Am. J. Epidemiol. 1998; 147: 903–910
   PubMed Web of Science ®Google Scholar
• Yamada K., Araki S., Tamura M., et al. Case-Control Study of Colorectal Carcinoma In Situ and Cancer in Relation to Cigarette Smoking and Alcohol Use (Japan). Cancer Causes Control 1997; 8: 780–785
   PubMed Web of Science ®Google Scholar
• Nyren O., Bergstrom R., Nystrom L., et al. Smoking and Colorectal Cancer: A 20-Year Follow-Up Study of Swedish Construction Workers. J. Natl. Cancer Inst. 1996; 88: 1302–1307
   PubMed Web of Science ®Google Scholar
• D'Avanzo B., La Vecchia C., Franceschi S., et al. Cigarette Smoking and Colorectal Cancer: A Study of 1584 Cases and 2879 Controls. Prev. Med. 1995; 24: 571–579
   PubMed Web of Science ®Google Scholar
• Heineman E. F., Zahm S. H., McLaughlin J. K., et al. Increased Risk of Colorectal Cancer Among Smokers: Results of a 26-Year Follow-Up of U. S. Veterans and a Review. Int. J. Cancer 1994; 59: 728–738
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Vogelstein B. A Genetic Model for Colorectal Tumorigenesis. Cell 1990; 61: 759–767
   PubMed Web of Science ®Google Scholar
• Fearon E. R. Molecular Genetic Studies of the Adenoma- Carcinoma Sequence. Adv. Intern. Med. 1993; 39: 123–147
   Google Scholar
• Hamilton S. R. Molecular Genetics of Colorectal Carcinoma. Cancer 1992; 70 (suppl): 1216s–1221s
   Web of Science ®Google Scholar
• Vogelstein B., Fearon E. R., Hamilton S. R., et al. Genetic Alterations During Colorectal-Tumor Development. N. Engl. J. Med. 1988; 319: 525–532
   PubMed Web of Science ®Google Scholar
• Cho K. P., Vogelstein B. Genetic Alterations in the Adenoma-Carcinoma Sequence. Cancer 1992; 70 (suppl): 1727–1731
   Web of Science ®Google Scholar
• Powell S. M., Zilz N., Beazer-Barclay Y., et al. APC Mutations Occur Early During Colorectal Tumorigenesis. Nature 1993; 359: 235–237
   Web of Science ®Google Scholar
• Counts J., Goodman J. Alterations in DNA Methylation May Play a Variety of Roles in Carcinogenesis. Cell 1995; 83: 13–15
   PubMed Web of Science ®Google Scholar
• Bos J. L. The ras Gene Family and Human Carcinogenesis. Mutat. Res. 1988; 195: 255–271
   PubMed Web of Science ®Google Scholar
• Shibata D., Peinado M. A., Ionov Y., et al. Genomic Instability in Repeated Sequences Is an Early Somatic Event in Colorectal Tumorigenesis that Persists After Transformation. Nature Genetics 1994; 6: 273–81
   PubMed Web of Science ®Google Scholar
• Hedrick L., Cho K. R., Fearon E. R., et al. The DCC Gene Product in Cellular Differentiation and Colorectal Tumorigenesis. Genes Dev. 1994; 8: 1174–1183
   PubMed Web of Science ®Google Scholar
• Thun M. J. NSAID Use and Decreased Risk of Gastrointestinal Cancers. Gastroenterol. Clin. North Am. 1996; 25: 333–348
   PubMed Web of Science ®Google Scholar
• Sturmer T., Glynn R. J., Lee I. M., et al. Aspirin Use and Colorectal Cancer: Post-Trial Follow-Up Data from the Physician's Health Study. Ann. Intern. Med. 1998; 128: 713–720
   PubMed Web of Science ®Google Scholar
• Sandler R. S., Galanko J. C., Murray S. C., et al. Aspirin and Nonsteroidal Anti-Inflammatory Agents and Risk for Colorectal Adenomas. Gastroenterology 1998; 114: 441–447
   PubMed Web of Science ®Google Scholar
• Thun M. J. Aspirin and Gastrointestinal Cancer. Adv. Exp. Med. Biol. 1997; 400A: 395–402
   PubMed Web of Science ®Google Scholar
• Kalgutkar A. S., Crews B. C., Rowlinson S. W., Garner C., Seibert K., Marnett L. J. Aspirin-Like Molecules that Covalently Inactivate Cyclooxygenase-2. Science 1998; 280: 1268–1270
   PubMed Web of Science ®Google Scholar
• Barnes C. J., Cameron I. L., Hardman W. E., Lee M. Non-Steroidal Anti-Inflammatory Drug Effect on Crypt Cell Proliferation and Apoptosis During Initiation of Rat Colon Carcinogenesis. Br. J. Cancer 1998; 77: 573–580
   PubMed Web of Science ®Google Scholar
• Friend W. G. Sulindac Suppression of Colorectal Polyps in Gardner's Syndrome. Am. Fam. Physician 1990; 41: 891–894
   PubMed Web of Science ®Google Scholar
• Gonzaga R. A.F., Lima F. R., Carneiro S., et al. Sulindac Treatment for Familial Polyposis Coli. Lancet 1985; 1: 751, (letter)
   PubMed Web of Science ®Google Scholar
• Rigau J., Pigue J. M., Rubio E., et al. Effects of Long- Term Sulindac Therapy on Colonic Polyposis. Ann. Intern. Med. 1991; 32: 952–954
   Google Scholar
• Giardiello F. M., Hamilton S. R., Krush A. J., et al. Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomaous Polyposis. N. Engl. J. Med. 1993; 328: 1313–1316
   PubMed Web of Science ®Google Scholar
• Labayle D., Fisher D., Vielh P., et al. Sulindac Causes Regression of Rectal Polyps in Familial Adenomatous Polyposis. Gastroenterology 1991; 101: 635–639
   PubMed Web of Science ®Google Scholar
• Powell S. M., Zilz N., Beazer-Barclay Y., et al. APC Mutations Occur Early During Colorectal Tumorigenesis. Nature 1992; 359: 235–237
   PubMed Web of Science ®Google Scholar
• His L. C., Angerman-Stewart J., Eling T. E. Introduction of Full Length APC Modulates Cyclooxygenase-2 Expression in HT-29 Human Colorectal Carcinoma Cells at the Translational Level. Carcinogenesis 1999; 20: 2045–2049
   PubMed Web of Science ®Google Scholar
• Reed J. C. Bcl-2 and the Regulation of Programmed Cell Death. J. Cell. Biol. 1994; 124: 1–6
   PubMed Web of Science ®Google Scholar
• Bissonnette R. P., Echeverri F., Mahboubi A., et al. Apoptotic Cell Death Induced by c-myc Is Inhibited by bcl-2. Nature 1992; 359: 552–554
   PubMed Web of Science ®Google Scholar
• Hauge A., Moorghen M., Hicks D., et al. Bcl-2 Expression in Human Colorectal Adenomas and Carcinomas. Oncogene 1994; 9: 3367–3370
   PubMed Web of Science ®Google Scholar
• Bronner M. P., Culin C., Reed J. C., et al. The bcl-2 Proto-Oncogene and the Gastrointestinal Epithelial Tumor Progression Model. Am. J. Pathol. 1995; 146: 20–26
   PubMed Web of Science ®Google Scholar
• Hague A., Manning A. M., Hanlon K. A., et al. Sodium Butyrate Induces Apoptosis in Human Colonic Tumour Cell Lines in a p53-Independent Pathway: Implications for the Possible Role of Dietary Fiber in the Prevention of Large-Bowel Cancer. Int. J.Cancer 1993; 55: 498–505
   PubMed Web of Science ®Google Scholar
• Mandel M., Kumar R. Bcl-2 Expression Regulates Sodium Butyrate-Induced Human MCF-7 Breast Cells. Cell Growth Differentiation 1996; 7: 311–318
   PubMedGoogle Scholar
• Mandel M., Wu K., Kumar R. Bcl-2 Deregulation Leads to Inhibition of Sodium Butyrate-Induced Apoptosis in Human Colorectal Carcinoma Cells. Carcinogenesis 1997; 18: 229–232
   PubMed Web of Science ®Google Scholar
• Bos J. L. Ras Oncogenes in Human Cancer: A Review. Cancer Res. 1989; 49: 4682–4689
   PubMed Web of Science ®Google Scholar
• Bos J. L., Fearon E. R., Hamilton S. R., et al. Prevalence of ras-Gene Mutations in Human Colorectal Cancers. Nature 1987; 327: 293–297
   PubMed Web of Science ®Google Scholar
• Andreyev H. F., Norman A. R., Cunningham D., Oats J. R., Clarke P. A. Kirsten ras Mutations in Patients with Colorectal Cancer: The Multicenter “RASCAL” Study. J. Natl. Cancer Inst. 1998; 90: 675–684
   PubMed Web of Science ®Google Scholar
• Burmer G. C., Loeb L. A. Mutations in the KRAS2 Oncogene During Progressive Stages of Human Colon Carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1989; 86: 2403–2407
   PubMed Web of Science ®Google Scholar
• Barbacid M. Ras Genes. Ann. Rev. Biochem. 1987; 56: 549–554
   Google Scholar
• Strauss B. S. The Origin of Point Mutations in Human Tumor Cells. Cancer Res. 1992; 52: 249–253
   PubMed Web of Science ®Google Scholar
• Dogliotti E. Mutational Spectra: From Model Systems to Cancer-Related Genes. Carcinogenesis 1996; 17: 2113–2118
   PubMed Web of Science ®Google Scholar
• Capella G., Cronauer-Mitra S., Peinado M. A., et al. Frequency and Spectrum of Mutations at Codons 12 and 13 of the c-K-ras Gene in Human Tumors. Environ. Health Perspect. 1991; 93: 125–131
   PubMed Web of Science ®Google Scholar
• Bingham S. A., Pignatelli B., Pollock J. R.A., et al. Does Increased Endogenous Formation of N-Nitroso Compounds in the Human Colon Explain the Association of Red Meat and Colon Cancer. Carcinogenesis 1996; 17: 515–523
   PubMed Web of Science ®Google Scholar
• Jacoby R. F., Alexander R. J., Raicht R. F., et al. K-ras Oncogene Mutations in Rat Colon Tumours Induced by MNU. Carcinogenesis 1992; 13: 45–49
   PubMed Web of Science ®Google Scholar
• Mirvish S. S. Role of N-Nitroso Compounds (NOC) and N-Nitrosation in Etiology of Gastric, Esophageal, Nasopharyngeal and Bladder Cancer and Contribution to Cancer of Known Exposures to NOC. Cancer Lett. 1995; 93: 17–48
   PubMed Web of Science ®Google Scholar
• Morotomi M., Guillem J., LoGerfo P., et al. Production of Diacylglycerol, an Activator of Protein Kinase C, by Human Intestinal Microflora. Cancer Res. 1990; 50: 3595–3599
   PubMed Web of Science ®Google Scholar
• Guillem J. G., Weinstein I. B. The Role of Protein Kinase C in Colon Neoplasia. Familial Adenomatous Polyposis, L. Herrar. Liss, New York 1990; 325–332
   Google Scholar
• Steinbach G., Morotomi M., Nomoto K., et al. Calcium Reduces the Increased Fecal 1,2-sn-Diacylglycerol Content in Intestinal Bypass Patients: A Possible Mechanism for Altering Colonic Hyperproliferation. Cancer Res. 1994; 54: 1216–1219
   PubMed Web of Science ®Google Scholar
• Sorenson A. W., Slattery M. L., Ford M. H. Calcium and Colon Cancer: A Review. Nutr. Cancer 1988; 11: 135–145
   PubMed Web of Science ®Google Scholar
• Llor X., Jacoby R. F., Teng B. B., et al. K-ras Muations in 1,2-Dimethylhydrazine-Induced Colonic Tumors: Effects of Supplemental Dietary Calcium and Vitamin D Deficiency. Cancer Res. 1991; 51: 4305–4309
   PubMed Web of Science ®Google Scholar
• Bautista D., Obrador A., Moreno V., Cabeza E., Canet R., Benito E., Bosch X., Costa J. Ki-ras Mutation Modifies the Protective Effect of Dietary Monounsaturated Fat and Calcium on Sporadic Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev. 1997; 6: 57–61
   PubMed Web of Science ®Google Scholar
• Martinez M. E., Maltzman T., Marshall J. R., Einspahr J., Reid M. E., Sampliner R., Ahnen D. J., Hamilton S. R., Alberts D. S. Risk Factors for Ki-ras Protooncogene Mutation in Sporadic Colorectal Adenomas. Cancer Res. 1999; 59: 5181–5185
   PubMed Web of Science ®Google Scholar
• Ookawa K., Sakamoto M., Hirohashi S., et al. Concordant p53 and DCC Alterations and Allelic Losses on Chromosomes 13q and 14q Associated with Liver Metastases of Colorectal Carcinoma. Int. J. Cancer 1993; 53: 382–387
   PubMed Web of Science ®Google Scholar
• Fazeli A., Dickinson S. L., Hermiston M. L., et al. Phenotype of Mice Lacking Functional Deleted in Colorectal Cancer (DCC) Gene. Nature 1997; 386: 796–804
   PubMedGoogle Scholar
• Schmitt C. A., Thaler K. R., Wittig B. M., et al. Detection of the DCC Gene Product in Normal and Malignant Colorectal Tissues and Its Relation to a Codon 201 Mutation. Br. J. Cancer 1998; 77: 588–594
   PubMed Web of Science ®Google Scholar
• Fearon E. R., Cho K. R., Nigro J. M., et al. Identification of a Chromosome 18q Gene That Is Altered in Colorectal Cancers. Science 1990; 247: 29–56
   Google Scholar
• Shibata D., Reale M. A., Lavin P., et al. Loss of DCC Expression and Prognosis in Colorectal Cancer. N. Engl. J. Med. 1996; 335: 1727–1732
   PubMed Web of Science ®Google Scholar
• Harris C. C. p53: At the Crossroads of Molecular Carcinogenesis and Risk Assessment. Science 1993; 262: 1980–1981
   PubMed Web of Science ®Google Scholar
• Hollstein M., Sidransky D., Vogelstein B., et al. p53 Mutations in Human Cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Jones P. A., Buckley J. D., Henderson B. E., et al. From Gene to Carcinogen: A Rapidly Evolving Field in Molecular Epidemiology. Cancer Res. 1991; 51: 3617–3620
   PubMed Web of Science ®Google Scholar
• Chiba I., Takahashi T., Nau M. M., et al. Mutations in the p53 Gene Are Frequent in Primary, Resected Non- 536 Ishibe and Freedman Small Cell Lung Cancer. Oncogene 1990; 5: 1603–1610
   PubMed Web of Science ®Google Scholar
• Tornaletti S., Pfeifer G. P. Complete and Tissue-Independent Methylation of CpG Sites in the p53 Gene: Implications for Mutations in Human Cancers. Oncogene 1995; 10: 1493–1499
   PubMed Web of Science ®Google Scholar
• Ishioka C., Suzuki T., Kanamaru R. Mutations of p53 Gene in Human Colorectal Tumor in Japan: Molecular Epidemiological Aspects. Tohoku J. Exp. Med. 1992; 167: 243–245
   PubMed Web of Science ®Google Scholar
• Makino H., Ushijima T., Kakiuchi H., et al. Absence of p53 Mutations in Rat Colon Tumors Induced by 2-Amino-6-methyl-dipyrido[1,2-a:3 ′, 2 ′ -d]imidazole, 2- amino-3-methylimidazo[4,5-f]quinoline, or 2-amino-1- methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res. 1994; 85: 510–514
   PubMedGoogle Scholar
• Schwartz J. L. Molecular and Biochemical Control of Tumor Growth Following Treatments with Carotenoids or Tocopherols. Nutrition and Cancer Prevention and Treatment, K. Prasad, L. Santamaria, R. M. Williams. Humana, Totawa, NJ 1994; 287–316
   Google Scholar
• Hamilton S. R. Molecular Genetic Alterations as Potential Prognostic Indicators in Colorectal Carcinoma. Cancer 1992; 69: 1589–1591
   PubMed Web of Science ®Google Scholar
• Freedman A. N., Michalek A. M., Marshall J. R., et al. Familial and Nutritional Risk Factors for p53 Overexpression in Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev. 1996; 5: 285–291
   PubMed Web of Science ®Google Scholar
• Freedman A. N., Michalek A. M., Marshall J. R., et al. The Relationship Between Smoking History and p53 Overexpression in Colorectal Cancer. Br. J. Cancer 1996; 73: 902–908
   PubMed Web of Science ®Google Scholar
• Freedman A. N., Michalek A. M., Zhang Z. F., et al. Dietary Risk Factors for p53 Overexpression in Distal Colorectal Cancer. Am. Assoc. Cancer Res. 1996, April (abstract)
   Google Scholar
• Obrador A., Moreno V., Bautista D., Cabeza E., Canet R., Benito E., Bosch X., Costa J. Colorectal Cancer, Diet and p53. Gastroenterology 1998; 114(4 (suppl S)), G2705, Part 2
   Google Scholar
• Wink D. A., Kasprzak K. S., Maragos C. M. DNA Deaminating Ability and Genotoxicity of Nitric Oxide and Its Progenitors. Science 1991; 254: 1001–1003
   PubMed Web of Science ®Google Scholar
• Voskuil D. W., Kampman E., van Kraats A. A., Balder H. F., van Muijen G. N.P., Goldbohm R. A., van't Veer Pieter P. P53 Overexpression and p53 Mutations in Colon Carcinomas: Relation to Dietary Risk Factors. Int. J. Cancer 1999; 81: 675–681
   PubMed Web of Science ®Google Scholar
• Ponce-Castanede M. V., Lee M. H., Latres E., et al. p27kip1: Chromosomal Mapping to 12p12-12p13.1 and Absence of Mutations in Human Tumors. Cancer Res. 1995; 55: 1211–1214
   PubMed Web of Science ®Google Scholar
• Kawamata N., Morosetti R., Miller C. W., et al. Molecular Analysis of the Cyclin-Dependent Kinase Inhibitor Gene p27kip1 in Human Malignancies. Cancer Res. 1995; 55: 2266–2269
   PubMed Web of Science ®Google Scholar
• Hengst L., Reed S. I. Translational Control of p27kip1 Accumulation During the Cell Cycle. Science 1996; 271: 1861–1864
   PubMed Web of Science ®Google Scholar
• Pagano M., Tam S. W., Theodoras A. M., et al. Role of the Ubiquitin-Proteasome Pathway in Regulating Abundance of the Cyclin-Dependent Kinase Inhibitor p27. Science 1995; 269: 682–685
   PubMed Web of Science ®Google Scholar
• Frederdorf S., Burns J., Milne A. M., et al. High Level Expression of p27kip1 and Cyclin D1 in Some Human Breast Cancer Cells: Inverse Correlation Between the Expression of p27kip1 and Degree of Malignancy in the Human Breast and Colorectal Cancers. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 6380–6385
   PubMed Web of Science ®Google Scholar
• Loda M., Cukor B., Tam S. W., et al. Increased Proteasome-Dependent Degradation of the Cyclin-Dependent Kinase Inhibitor p27 in Aggressive Colorectal Carcinomas. Nature Med. 1997; 3: 231–234
   PubMed Web of Science ®Google Scholar
• Sgambato A., Ratto C., Faraglia B., Merico M., Ardito R., Schinzari G., Romano G., Cittadini A. R.M. Reduced Expression and Altered Subcellular Localization of the Cyclin-Dependent Kinase Inhibitor p27>kip1 in Human Colon Cancer. Mol. Carcinog. 1999; 26: 172–179
   PubMed Web of Science ®Google Scholar
• Thomas G. V., Szigeti K., Murphy M., Draetta G., Pagano M., Loda M. Down-Regulation of p27 Is Associated with Development of Colorectal Adenocarcinoma Metastases. Am. J. Pathol. 1998; 153: 681–687
   PubMed Web of Science ®Google Scholar
• Ishibe N., Freedman A. N., Michalek A. M., Iacobuzio-Donahue C., Mettlin C. J., Petrelli N. J., Asirwatham J. E., Hamilton S. R. Expression of p27 and bcl-2 and Cigarette Smoking in Colorectal Cancer Risk. Biomarkers 2000; 5: 225–234
   PubMed Web of Science ®Google Scholar
• Lynch H. T., Watson P., Smyrk T. C., et al. Colon Cancer Genetics. Cancer 1992; 70 (suppl): 1300–1311.117
   Web of Science ®Google Scholar
• Lynch H. T., Smyrk T. Hereditary Nonpolyposis Colorectal Cancer (Lynch Syndrome): An Updated Review. Cancer 1996; 78: 1149–1167
   PubMed Web of Science ®Google Scholar
• Soliman A. S., Bondy M. L., Guan Y., et al. Reduced Expression of Mismatch Repair Genes in Colorectal Cancer Patients in Egypt. Int. J. Oncol. 1998; 12: 1315–1319
   PubMed Web of Science ®Google Scholar
• Herman J. G., Umar A., Polyak K., et al. Incidence and Functional Consequences of hMLH1 Promoter Hypermethylation in Colorectal Carcinoma. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 6870–6875
   PubMed Web of Science ®Google Scholar
• Ruschoff J., Wallinger S., Dietmaier W., et al. Aspirin Suppresses the Mutator Phenotype Associated with Hereditary Nonpolyposis Colorectal Cancer by Genetic Selection. Proc. Natl. Acad. Sci. U.S.A. 1998; 95: 11301–11306
   PubMed Web of Science ®Google Scholar
• Oesch F., Klein S. Relevance of Environmental Alkylating Agents to Repair O6-Alkylguanine-DNA Alkyltransferase: Determination of Individual and Collective Repair Capacities of O6-Methylguanine. Cancer Res. 1992; 52: 1801–1803
   PubMed Web of Science ®Google Scholar
• Au W. W., Wilkinson G. S., Tyring S. K., et al. Monitoring Populations for DNA Repair Deficiency and for Cancer Susceptibility. Environ. Health Perspect. 1996; 104: 579–584
   PubMed Web of Science ®Google Scholar
• Souliotis V. L., Valavanis C., Boussiotis V. A., et al. Comparative Study of the Formation and Repair of O6- Methylguanine in Humans and Rodents Treated with Dicarbazine. Carcinogenesis 1996; 17: 725–732
   PubMed Web of Science ®Google Scholar
• Hamilton S. R. The Molecular Genetics of Colorectal Neoplasia. Gastroenterology 1993; 105: 3–7
   PubMed Web of Science ®Google Scholar
• Jones P. A., Buckley J. D. The Role of DNA Methylation in Cancer. Adv. Cancer Res. 1990; 54: 1–23
   PubMedGoogle Scholar
• Giovanucci E., Stampfer M. J., Colditz G. A., et al. Folate, Methionine, and Alcohol Intake and Risk of Colorectal Adenoma. J. Natl. Cancer Inst. 1993; 85: 875–884
   PubMed Web of Science ®Google Scholar
• Freudenheim J. L., Graham S., Marshall J. R., et al. Folate Intake and Carcinogenesis of the Colon and Rectum. Int. J. Epidemiol. 1991; 20: 368–374
   PubMed Web of Science ®Google Scholar
• Benito E., Stiggelbout A., Bosch F. X., et al. Nutritional Factors in Colorectal Cancer Risk: A Case-Control Study in Majorca. Int. J. Cancer 1991; 49: 161–167
   PubMed Web of Science ®Google Scholar
• MacGregor J. T., Wehr C. M., Hiatt R. A., et al. ‘Spontaneous' Genetic Damage in Man: Evaluation of Inter-Individual Variability, Relationship Among Markers of Damage, and Influence of Nutritional Status. Mutat. Res. 1997; 377: 125–135
   PubMed Web of Science ®Google Scholar
• Blount B. C., Mack M. M., Wehr C. M., et al. Folate Deficiency Causes Uracil Misincorporation into Human DNA and Chromosome Breakage: Implications for Cancer and Neuronal Damage. Proc. Natl. Acad. Sci. U.S.A. 1997; 94: 3290–3299
   PubMed Web of Science ®Google Scholar
• Cravo M. L., Mason J. B., Dayal Y., et al. Folate Deficiency Enhances the Development of Colonic Neoplasia in Dimethylhydrazine-Treated Rats. Cancer Res. 1992; 52: 5002–5006
   PubMed Web of Science ®Google Scholar
• Schmutte C., Yang A. S., Nguyen T. T., et al. Mechanisms for the Involvement of DNA Methylation in Colon Carcinogenesis. Cancer Res. 1996; 56: 2375–2381
   PubMed Web of Science ®Google Scholar
• Goyette P., Sumner J. S., Milos R., et al. HumanMethylenetetrahydrofolate Reductase: Isolation of cDNA, Mapping and Mutation Identification. Nature Genet. 1994; 7: 195–200
   PubMed Web of Science ®Google Scholar
• Engbersen A. M., Franken D. G., Boers G. H., et al. Thermolabile 5,10-Methylenetetrahydrofolate Reductase as a Cause of Mild Hyperhomocysteinemia. Am. J. Hum. Genet. 1995; 56: 142–150
   PubMed Web of Science ®Google Scholar
• Zittoun J., Tonetti C., Bories D., et al. Plasma Homocysteine Levels Related to Interactions Between Folate Status and Methylenetetrahydrofolate Reductase: A Study in 52 Healthy Subjects. Metabolism 1998; 47: 1413–1418
   PubMed Web of Science ®Google Scholar
• Ou C. Y., Stevenson R. E., Brown V. K., et al. 5, 10- Methylenetetrahydrofolate Reductase Genetic Polymorphism as a Risk Factor for Neural Tube Defects. Am. J. Med. Genet. 1996; 63: 610–614
   PubMed Web of Science ®Google Scholar
• Chen J., Giovannucci E., Kelsey K. T., et al. A Methylenetetrahydrofolate Reductase Polymorphism and the Risk of Colorectal Cancer. Cancer Res. 1996; 56: 4862–4864
   PubMed Web of Science ®Google Scholar
• Slattery M. L., Potter J. D., Samowitz W., Schaffer D., Leppert M. Methylenetetrahydrofolate Reductase, Diet, and Risk of Colon Cancer. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 513–518
   PubMed Web of Science ®Google Scholar
• Chen J., Giovannucci E., Hankinson S., et al. A Prospective Study of Polymorphisms of Methylenetetreahydrofolate Reductase and Methionine Synthase and the Risk of Colorectal Adenoma. Carcinogenesis 1998; 19: 2129–2132
   PubMed Web of Science ®Google Scholar
• Park K. S., Mok J. W., Kim J. C. The 677C_T Mutation in 5,10-Methylenetetrahydrofolate Reductase and Colorectal Cancer Risk. Genetic Testing 1999; 3: 233–236
   PubMedGoogle Scholar
• Wisotzkey J. D., Toman J., Bell T., Monk J. S., Jones D. MTHFR (C677T) Polymorphisms and Stage III Colon Cancer: Response to Therapy. Mol. Diagn. 1999; 4: 95–99
   PubMedGoogle Scholar
• Flammang T. J., Couch L. H., Levy G. N., et al. DNAAdduct Levels in Congenic Rapid and Slow Acetylator Mouse Strains Following Chronic Administration of 4-Aminobiphenyl. Carcinogenesis 1992; 13: 1887–1891
   PubMed Web of Science ®Google Scholar
• Sinha R., Rothman N., Brown E. D., et al. High Concentrations of the Carcinogen 2-Amino-1-methyl- 6-phenylimidazo-[4,5-B]pyridine (PhIP) Occur in Chicken and Are Dependent on the Cooking Method. Cancer Res. 1995; 55: 4516–4519
   PubMed Web of Science ®Google Scholar
• Ohgaki H., Takayama J. R., Sugimura T. Carcinogenicities of Heterocyclic Amines in Cooked Food. Mutat. Res. 1991; 259: 399–410
   PubMed Web of Science ®Google Scholar
• Ito R., Hasegawa R., Sano M., et al. A New Colon and Mammary Carcinogen in Cooked Food, 2-Amino- 1-methyl-6-phenylimidaso[4,5-b]pyridine (PhIP). Carcinogenesis 1991; 12: 1503–1506
   PubMed Web of Science ®Google Scholar
• Kakiuchi H., Watanabe M., Ushijima T., et al. Specific 5′ -GGGA-3′ GGA-3′ Mutation of the Apc Gene in Rat Colon Tumors Induced by 2-Amino-1-methyl- 6-phenylimadazo(4,5-b)pyridine. Proc. Natl. Acad. Sci. U.S.A. 1995; 92: 910–914
   PubMed Web of Science ®Google Scholar
• Miyaki M., Konishi M., Kikuchi-Yanoshita R., et al. Characteristics of Somatic Mutation of the Adenomatous Polyposis Coli Gene in Colorectal Tumors. Cancer Res. 1994; 54: 3011–3020
   PubMed Web of Science ®Google Scholar
• Gerhardsson de Verdier M., Hagman U., Peters R. K., Steineck G., Overvik E. Meat, Cooking Methods and Colorectal Cancer: A Case-Referent Study in Stockholm. Int. J. Cancer 1991; 49: 520–525
   PubMed Web of Science ®Google Scholar
• Schiffman M. H., Felton J. S. Re: “Fried Foods and Risk of Colon Cancer.”. Am. J. Epidemiol. 1990; 131: 376–378
   PubMed Web of Science ®Google Scholar
• Peters R. K., Garabrant D. H., Yu M. C., Mack T. A Case-Control Study of Occupational and Dietary Factors in Colorectal Cancer in Young Men by Subsite. Cancer Res. 1989; 49: 5459–5468
   PubMed Web of Science ®Google Scholar
• Lyon J. L., Mahoney A. W. Fried Foods and Risk of Colon Cancer. Am. J. Epidemiol. 1988; 128: 1000–1006
   PubMed Web of Science ®Google Scholar
• Muscat J. E., Wynder E. L. The Consumption of Well- Done Red Meat and the Risk of Colorectal Cancer. Am. J. Public Health 1994; 84: 856–858
   PubMed Web of Science ®Google Scholar
• Vatsis K. P., Weber W. W., Bell D. A., et al. Nomenclature for N-Acetyltransferases. Pharmacogenetics 1995; 5: 1–17
   PubMedGoogle Scholar
• Lang N. P., Chu D. Z., Hunter C. F., et al. Role of Aromatic Amine Acetyltransferase in Human Colorectal Cancer. Arch. Surg. 1986; 121: 1259–1261
   PubMed Web of Science ®Google Scholar
• Wohileb J. C., Hunter C. F., Blass B., et al. Aromatic Amine Acetyltransferase as a Marker for Colorectal Cancer: Environmental and Demographic Associations. Int. J. Cancer 1990; 46: 22–30
   PubMed Web of Science ®Google Scholar
• Roberts-Thomson I. C., Ryan P., Khoo K. K., et al. Diet, Acetylator Phenotype, and Risk of Colorectal Neoplasia. Lancet 1996; 347: 1372–1374
   PubMed Web of Science ®Google Scholar
• Feng Y., Fretland A. J., Rustan T. D., et al. Higher Frequency of Aberrant Crypt Foci in Rapid than Slow Acetylator Inbred Rats Administered the Colon Carcinogen 3,2′-Dimethyl-4-aminobiphenyl. Toxicol. Appl. Pharmacol. 1997; 147: 56–62
   PubMed Web of Science ®Google Scholar
• Levy G. N., Weber W. W. 2-Aminofluorene-DNA Adduct Formation in Acetylator Congenic Mouse Lines. Carcinogenesis 1989; 10: 705–709
   PubMed Web of Science ®Google Scholar
• Paulsen J. E.I., Steffensen I. L., Namork E., et al. Effect of Acetylator Genotype on 3,2′-Dimethyl-4-aminobiphenyl Induced Aberrant Crypt Foci in the Colon of Hamsters. Carcinogenesis 1996; 17: 459–465
   PubMed Web of Science ®Google Scholar
• Flammang T. J., Couch L. H., Levy G. N., et al. DNAAdduct Levels in Congenic Rapid and Slow Acetylator Mice Strains Following Chronic Administration of 4- Aminobiphenyl. Carcinogenesis 1992; 13: 1887–1891
   PubMed Web of Science ®Google Scholar
• Chen J., Stampfer M. J., Hough H. L., et al. A Prospective Study of N-Acetyltransferase Genotype, Red Meat Intake, and Risk of Colorectal Cancer. Proc. Am. Assoc. Cancer Res. 1998; 39: 366
   Google Scholar
• Hubbard A. L., Harrison D. J., Moyes C., et al. N-Acetyltransferase 2 Genotype in Colorectal Cancer and Selective Gene Retention in Cancers with Chromosome 8p Deletions. Gut 1997; 41: 229–234
   PubMed Web of Science ®Google Scholar
• Welfare M. R., Cooper J., Bassendine M. F., et al. Relationship Between Acetylator Status, Smoking, and Diet and Colorectal Cancer Risk in the Northeast of England. Carcinogenesis 1997; 18: 1351–1354
   PubMed Web of Science ®Google Scholar
• Rodriguez J. W., Ward G. K., Ferguson R. J., et al. Human Acetylator Genotype: Relationship to Colorectal Cancer Incidence and Arylamine N-Acetyltransferase Expression in Colon Cytosol. Arc. Toxicol. 1993; 67: 445–452
   PubMed Web of Science ®Google Scholar
• Oda Y., Tanaka M., Nakanishi I. Relation Between the Occurrence ofK-rasGene Point Mutations and Genotypes of Polymorphic N-Acetyltransferase in Human Colorectal Carcinomas. Carcinogenesis 1994; 15: 1365–1369
   PubMed Web of Science ®Google Scholar
• Shibuta K., Nakashima T., Abe M., et al. Molecular Genotyping for N-Acetylation Polymorphism in Japanese Patients with Colorectal Cancer. Cancer 1994; 74: 3108–3112
   PubMed Web of Science ®Google Scholar
• Probst-Hensch N. M., Haile R. W., Ingles S. A., et al. Acetylation Polymorphism and Prevalence of Colorectal Adenomas. Cancer Res. 1995; 55: 2017–2020
   PubMed Web of Science ®Google Scholar
• Yoshioka M., Katho T., Nakano M., Takasawa S., Nagata N., Itoh H. Glutathione S-Transferase (GST) M1, T1, P1, N-Acetyltransferase (NAT) 1 and 2 Genetic Polymorphisms and Susceptibility to Colorectal Cancer. J. Univ. Occup. Environ. Health 1999; 21: 133–147
   Google Scholar
• Gil J. P., Lechner M. C. Increased Frequency of Wild- Type Arylamine-N-acetyltransferase Allele NAT2*4 Homozygotes in Portuguese Patients with Colorectal Cancer. Carcinogenesis 1998; 19: 37–41
   PubMed Web of Science ®Google Scholar
• Kampman E., Slattery M. L., Bigler J., Lepper M., Samowitz W., Caan B. J., Potter J. D. Meat Consumption, Genetic Susceptibility, and Colon Cancer Risk: A United States Multicenter Case-Control Study. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 15–24
   PubMed Web of Science ®Google Scholar
• Scott R. J., Taeschner W., Heinimann K., et al. Association of Extracolonic Manifestations of Familial Adenomatous Polyposis with Acetylation Phenotype in a Large FAP Kindred. Eur. J. Hum. Genet. 1997; 5: 43–49
   PubMed Web of Science ®Google Scholar
• Bell D. A., Stephens E. A., Castranio T., et al. Polyadenylation Polymorphism in the Acetyltransferase 1 Gene (NAT1) Increases Risk of Colorectal Cancer. Cancer Res. 1995; 55: 3537–3542
   PubMed Web of Science ®Google Scholar
• Turesky R. J., Lang N. P., Butler M. A., Teitel C. H., Kadlubar F. F. Metabolic Activation of Carcinogenic Heterocyclic Amines by Human Liver and Colon. Carcinogenesis 1991; 12: 1839–1845
   PubMed Web of Science ®Google Scholar
• Nebert D. W., McKinnon R. A., Puga A. Human Drug-Metabolizing Enzyme Polymorphisms: Effects on Risk of Toxicity and Cancer. DNA Cell Biol. 1996; 15: 273–280
   PubMed Web of Science ®Google Scholar
• Daly A. K. Molecular Basis of Polymorphic Drug Metabolism. J. Mol. Med. 1995; 73: 539–553
   PubMed Web of Science ®Google Scholar
• McWilliams J. E., Sanderson B. J., Harris E. L., et al. Glutathione S-Transferase M1 (GSTM1) Deficiency and Lung Cancer Risk. Cancer Epidemiol. Biomarkers Prev. 1995; 4: 589–594
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman S. Z., Anwar W. A., Abdel-Aal W. E., et al. GSTM1 and GSTT1 Genes Are Potential Risk Modifiers for Bladder Cancer. Cancer Detect. Prev. 1998; 22: 129–138
   PubMedGoogle Scholar
• Bell D. A., Taylor J. A., Paulson D. F., et al. Genetic Risk and Carcinogen Exposure: A Common Inherited Defect of the Carcinogen-Metabolism Gene Glutathione S-Transferase M1 (GSTM1) that Increases Susceptibility to Bladder Cancer. J. Natl. Cancer Inst. 1993; 85: 1159–1164
   PubMed Web of Science ®Google Scholar
• Zhong S., Wyllie A. H., Barnes D., et al. Between the GSTM1 Genetic Polymorphism and Susceptibility to Bladder, Breast and Colon Cancer. Carcinogenesis 1993; 14: 1821–1824
   PubMed Web of Science ®Google Scholar
• Chenevix-Trench G., Young J., Coggan M., et al. Glutathione S-Transferase M1 and T1 Polymorphisms: Susceptibility to Colon Cancer and Age of Onset. Carcinogenesis 1995; 16: 1655–1657
   PubMed Web of Science ®Google Scholar
• Deakin M., Elder J., Hendricksen C., et al. Glutathione S-Transferase GSTT1 Genotypes and Susceptibility to Cancer: Studies of Interactions with GSTM1 in Lung, Oral, Gastric and Colorectal Cancers. Carcinogenesis 1996; 17: 881–884
   PubMed Web of Science ®Google Scholar
• Gertig D. M., Stampfer M., Haiman C., Hennekens C. H., et al. Glutathione S-Transferase GSTM1 and GSTT1 Polymorphisms and Colorectal Cancer Risk: A Prospective Study. Cancer Epidemiol. Biomarkers Prev. 1998; 7: 1001–1005
   PubMed Web of Science ®Google Scholar
• Welfare M., Monesola Adeokun A., Bassendine M. F., Daly A. K. Polymorphisms in GSTP1 GSTM1 and GSTT1 and Susceptibility to Colorectal Cancer. Cancer Epidemiol. Biomarkers Prev. 1999; 8: 289–292
   PubMed Web of Science ®Google Scholar
• Gawronska-Szklarz B., Lubinski J., Kladny J., Kurzawski G., et al. Polymorphism of GSTM1 Gene in Patients with Colorectal Cancer and Colonic Polyps. Exp. Toxicol. Pathol. 1999; 51: 321–325
   PubMed Web of Science ®Google Scholar
• Katoh T., Nagata N., Kuroda Y., et al. Glutathione S-Transferase M1 (GSTM1) and T1 (GSTT1) Genetic Polymorphism and Susceptibility to Gastric and Colorectal Adenocarcinoma. Carcinogenesis 1996; 17: 1855–1859
   PubMed Web of Science ®Google Scholar
• DeMarini D. M., Hastings S. B., Brooks L. R., et al. Pilot Study of Free and Conjugated Urinary Mutagenicity During Consumption of Pan-Fried Meats: Possible Modulation by Cruciferous Vegetables, Glutathione STransferase- M1 and N-Acetyltransferase-2. Mutat. Res. 1997; 381: 38–96
   Google Scholar
• Lin H. J., Probst-Hensch N. M., Louie A. D., et al. Glutathione Transferase Null Genotype, Broccoli, and Lower Prevalence of Colorectal Adenomas. Cancer Epidemiol. Biomarkers Prev. 1998; 7: 647–652
   PubMed Web of Science ®Google Scholar
• Kelsey K. T., Nelson H. H., Wiencke J. K., et al. The Glutathione S-Transferase Theta and Mu Deletion Polymorphisms in Asbestosis. Am. J. Intern. Med. 1997; 31: 274–279
   Web of Science ®Google Scholar